Stonehouse Jon P bought BCRX
February 27, 2026 · Form 4 insider transaction
Stonehouse Jon P bought 421 shares of BioCryst Pharmaceuticals, Inc. at $8.75 per share, a transaction worth $3.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
421
Price
$8.75
Total value
$3.7K
InsiderStonehouse Jon P
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after1,323,850
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 50% of the prorated quarterly cash Board Member retainer of $7,375.